Aldwin Suryo Rahmanto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aldwin Suryo Rahmanto has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Olle Sangfelt
Department of Cell and Molecular Biology, Karolinska Institutet (KI), Sweden
41 shared publications - Fredrik Johansson Swartling
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
39 shared publications - Michael D. Taylor
Texas Children’s Hospital, Baylor College of Medicine , Houston, Texas
38 shared publications - Adrian M. Dubuc
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada
37 shared publications - Alexandra Garancher
Tumor Initi-ation & Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, San Diego, California
37 shared publications - Amelie S. Wenz
Uppsala University
37 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Results of differential gene expression analysis between GTML tumours and GTS tumours.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Results of differential gene expression analysis between GTML tumours and GTS tumours.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legends from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legends from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Results of differential gene expression analysis between pre-GTS1 tumor cells treated for 48 hours with DMSO or Dox.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Results of differential gene expression analysis between pre-GTS1 tumor cells treated for 48 hours with DMSO or Dox.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
List of genes that are part of a quiescent cell signature and display regions of differentially opened chromatin.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
List of genes that are part of a quiescent cell signature and display regions of differentially opened chromatin.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Results of differential gene expression analysis between GTML3 tumor cells treated for 48 hours with DMSO or Dox.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Results of differential gene expression analysis between GTML3 tumor cells treated for 48 hours with DMSO or Dox.